Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sami Labs is a research-driven health science company specializing in the development and manufacture of standardized herbal extracts, nutraceuticals, and specialty chemicals. Founded in 1991 by Dr. Muhammed Majeed, the company serves as the primary R&D and manufacturing arm of the global Sami-Sabinsa Group. Its business model integrates traditional Ayurvedic knowledge with modern scientific validation, resulting in a portfolio of over 400 granted patents worldwide. Key commercial products include Curcumin C3 Complex, BioPerine, and ForsLean, which are used extensively in the dietary supplement and functional food industries. The company operates multiple state-of-the-art manufacturing facilities in India and maintains a significant global presence through its distribution arm, Sabinsa Corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sami Labs.